參考文獻(xiàn)/References:
[1] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[2] 唐濤,茍遠(yuǎn)濤,唐俊,等.成都地區(qū)成人股骨頭壞死流行病學(xué)研究[J].中國(guó)康復(fù)理論與實(shí)踐,2018,24(8):970-974.
[3] MONT M A,HUNGERFORD D S.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[4] GARDENIERS J W M.Report of the committee of staging and nomenclature[EB/OL].(1993-10-14)[2019-08-03].http://arco-intl.org/Newsletters/Gardeniers-1993-5-2/Gardeniers-1993.htm.
[5] 李子榮,劉朝暉,孫偉,等.基于三柱結(jié)構(gòu)的股骨頭壞死分型——中日友好醫(yī)院分型[J].中華骨科雜志,2012,32(6):515-520.
[6] 陳衛(wèi)衡,劉道兵,張洪美,等.股骨頭壞死的三期四型辨證思路[J].中國(guó)中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2003,9(12):51-52.
[7] 國(guó)家中醫(yī)藥管理局.中醫(yī)病證診斷療效標(biāo)準(zhǔn)[M].南京:南京大學(xué)出版社,1994:193.
[8] 何偉.精確診斷前提下股骨頭壞死非手術(shù)治療實(shí)踐[J].臨床外科雜志,2017,25(8):580-582.
[9] 何偉,洪郭駒,張慶文,等.非創(chuàng)傷性股骨頭壞死中醫(yī)辨病相關(guān)古籍文獻(xiàn)內(nèi)容評(píng)析[J].時(shí)珍國(guó)醫(yī)國(guó)藥,2016,27(3):659-660.
[10] 吳紅富,王晶,張斌,等.石氏傷科治療激素性股骨頭壞死經(jīng)驗(yàn)初探[J].中華中醫(yī)藥雜志,2019,34(8):3541-3543.
[11] 張俐.中醫(yī)骨病學(xué)[M].北京:人民衛(wèi)生出版社,2012:116-127.
[12] 王和鳴.中醫(yī)骨傷科學(xué)[M].北京:中國(guó)中醫(yī)藥出版社,2017:338-340.
[13] 李泰賢,陳志偉,王榮田,等.基于文獻(xiàn)計(jì)量學(xué)分析中醫(yī)藥治療股骨頭壞死的研究現(xiàn)狀[J].中國(guó)中醫(yī)骨傷科雜志,2017,25(4):41-46.
[14] 中華中醫(yī)藥學(xué)會(huì).股骨頭壞死中醫(yī)辨證標(biāo)準(zhǔn)(2019年版)[J].中醫(yī)正骨,2019,31(6):1-2.
[15] 連曦敏,張一平.成人股骨頭缺血性壞死介入治療的價(jià)值探討[J].中國(guó)現(xiàn)代藥物應(yīng)用,2010,4(24):25-26.
[16] 尹嘯飛,周正新.中醫(yī)藥治療股骨頭壞死臨床研究進(jìn)展[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2018,20(2):218-220.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型
血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):7.
[4]鮑榮華,王國(guó)平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):14.
[9]鮑榮華,王國(guó)平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[11]陳衛(wèi)衡.中國(guó)股骨頭壞死數(shù)據(jù)庫(kù)的現(xiàn)狀與挑戰(zhàn)[J].中醫(yī)正骨,2020,32(01):1.
[12]雷志強(qiáng),曾平,陳衛(wèi)衡,等.中國(guó)股骨頭壞死數(shù)據(jù)庫(kù)股骨頭壞死流行病學(xué)特點(diǎn)分析[J].中醫(yī)正骨,2020,32(01):4.
[13]周占國(guó),郭浩山,關(guān)濤,等.股骨頭壞死病因的相關(guān)因素分析[J].中醫(yī)正骨,2020,32(01):7.
[14]陳瑞,董博,袁普衛(wèi),等.股骨頭壞死誤診原因分析[J].中醫(yī)正骨,2020,32(01):11.
[15]楊琪,杜炯,孫繼高,等.股骨頭壞死中醫(yī)證型分析[J].中醫(yī)正骨,2020,32(01):14.
[16]莊至坤,郭金花,趙巖,等.股骨頭壞死髖關(guān)節(jié)疼痛和活動(dòng)度與ARCO分期的相關(guān)性分析[J].中醫(yī)正骨,2020,32(01):21.
[17]范亞楠,李文龍,張穎,等.不同病因股骨頭壞死的ARCO分期和中日友好醫(yī)院分型特征研究[J].中醫(yī)正骨,2020,32(01):25.
[18]高歡歡,王向鵬,任浩,等.股骨頭壞死的舌象特征研究[J].中醫(yī)正骨,2020,32(01):28.
[19]薛志鵬,李記天,高歡歡,等.股骨頭壞死舌象特點(diǎn)的聚類分析[J].中醫(yī)正骨,2020,32(01):32.
[20]宋夢(mèng)歌,李記天,薛志鵬,等.股骨頭壞死保髖治療的臨床療效分析[J].中醫(yī)正骨,2020,32(01):36.